Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Caris Life Sciences, Inc. | 119,868 | reported | 26 Feb 2026 | tx 3+103,739−100,000 |
| ADVANCEPCS | 53,000 | reported | 09 Mar 2004 | tx 30+477,000−1,026,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Feb 2026 | GRANT_AWARD | Caris Life Sciences, Inc. | 3,739 | 20.06 USD | |
| 11 Sept 2025 | EXERCISE | Caris Life Sciences, Inc. | 100,000 | 2.44 USD | |
| 11 Sept 2025 | EXERCISE | Caris Life Sciences, Inc. | 100,000 | 0.00 USD | deriv |
| 09 Mar 2004 | SALE | ADVANCEPCS | 100 | 73.09 USD | |
| 09 Mar 2004 | SALE | ADVANCEPCS | 38,100 | 73.00 USD | |
| 08 Mar 2004 | EXERCISE | ADVANCEPCS | 10,700 | 2.25 USD | |
| 09 Mar 2004 | EXERCISE | ADVANCEPCS | 29,300 | 2.25 USD | |
| 08 Mar 2004 | SALE | ADVANCEPCS | 10,700 | 72.50 USD | |
| 09 Mar 2004 | SALE | ADVANCEPCS | 100 | 73.03 USD | |
| 08 Mar 2004 | EXERCISE | ADVANCEPCS | 10,700 | 0.00 USD | deriv |
| 09 Mar 2004 | EXERCISE | ADVANCEPCS | 29,300 | 0.00 USD | deriv |
| 03 Mar 2004 | EXERCISE | ADVANCEPCS | 3,888 | 3.13 USD | |
| 03 Mar 2004 | EXERCISE | ADVANCEPCS | 36,766 | 7.34 USD | |
| 03 Mar 2004 | EXERCISE | ADVANCEPCS | 1,346 | 7.34 USD | |
| 03 Mar 2004 | EXERCISE | ADVANCEPCS | 117,288 | 9.34 USD | |
| 03 Mar 2004 | EXERCISE | ADVANCEPCS | 10,712 | 9.34 USD | |
| 03 Mar 2004 | EXERCISE | ADVANCEPCS | 120,000 | 10.00 USD | |
| 03 Mar 2004 | EXERCISE | ADVANCEPCS | 10,000 | 28.65 USD | |
| 03 Mar 2004 | SALE | ADVANCEPCS | 300,000 | 70.44 USD | |
| 04 Mar 2004 | EXERCISE | ADVANCEPCS | 75,000 | 2.25 USD | |
| 04 Mar 2004 | EXERCISE | ADVANCEPCS | 22,972 | 3.13 USD | |
| 04 Mar 2004 | EXERCISE | ADVANCEPCS | 39,028 | 7.34 USD | |
| 04 Mar 2004 | SALE | ADVANCEPCS | 200,000 | 71.75 USD | |
| 03 Mar 2004 | EXERCISE | ADVANCEPCS | 3,888 | 0.00 USD | deriv |
| 03 Mar 2004 | EXERCISE | ADVANCEPCS | 36,766 | 0.00 USD | deriv |